Primary (AL) amyloidosis is the most prevalent type of systemic amyloidosis, and management of this disease has evolved through the years from supportive care to aggressive treatments that include ...

The challenge in this case was the determination of primary amyloidosis. Virtually all patients with AL amyloidosis have elevations of the responsible FLC. In this patient, the initial concern was ...

Misfolded proteins not only lose their normal physiological functions, but can also acquire new properties that drive pathological processes leading to disease. Amyloid plaques comprising tangled ...

The trial tested subcutaneous daratumumab in combination with bortezomib, cyclophosphamide and dexamethasone (D-VCd) compared to VCd alone and met its primary ... amyloidosis, it remains a rare ...

UK: A recent retrospective cohort study has highlighted the critical role of kidney function in patients diagnosed with ...

The Food and Drug Administration (FDA) has approved Attruby TM (acoramidis) for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to ...